Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer
Open Access
- 1 November 1996
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 74 (9) , 1479-1481
- https://doi.org/10.1038/bjc.1996.568
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125.Journal of Clinical Oncology, 1996
- Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group studyAnnals of Oncology, 1996
- Cutaneous T-cell lymphoma and calcitriol and isotretinoin treatmentThe Lancet, 1995
- Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesionsThe Lancet, 1994
- Remission of cutaneous T-cell lymphoma with combined calcitriol and acitretinThe Lancet, 1994
- Response of four human ovarian carcinoma cell lines to ALL‐TRANS retinoic acid: Relationship with induction of differentiation and retinoic acid receptor expressionInternational Journal of Cancer, 1994
- 13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the CervixJNCI Journal of the National Cancer Institute, 1992
- Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphomaBritish Journal of Cancer, 1991
- Topical calcipotriol treatment in advanced breast cancerThe Lancet, 1991
- The role of CA 125 in the early diagnosis of progressive disease in ovarian cancerAnnals of Oncology, 1990